期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Human papilloma virus vaccination: Review article and an update
1
作者 Zahra Maleki 《World Journal of Obstetrics and Gynecology》 2016年第1期16-27,共12页
Human papilloma virus(HPV) is sexually transmitted and associated with uterine cervix, vaginal, and vulvar cancers in females, oropharyngeal and anal cancer in both genders, and penile cancer in males. Moreover, genit... Human papilloma virus(HPV) is sexually transmitted and associated with uterine cervix, vaginal, and vulvar cancers in females, oropharyngeal and anal cancer in both genders, and penile cancer in males. Moreover, genital warts are benign tumors which are HPV-related and can occur in both genders. This is a review of HPV structure, HPV infection transmission, the global impact of HPV and its associated diseases, HPV vaccines and their efficacy and safety, public acceptance of HPV vaccines, the obstacles for its acceptance and strategies to address the barriers. Cervarix(a bivalent vaccine with protection against HPV types 16 and 18) and Gardasil(a quadrivalent vaccine with protection against HPV types 6, 11, 16 and 18) are 2 recommended vaccines. The longest follow up of 9.4 years has shown efficacy and protection of the vaccine against HPV types 16 and 18. The adverse effects have been minimal and the vaccine is considered safe. Numerous studies are conducted to follow the vaccinated individuals to better understand the effect of HPV vaccine on incidence of HPV-related cancers and precancerous lesions. 展开更多
关键词 性传播 疾病 生殖健康 治疗方法
下载PDF
How Silencing of Dissent in Science Impacts Woman.The Gardasil^(■)Story
2
作者 Leonard F.Vernon 《Advances in Sexual Medicine》 2017年第4期179-204,共26页
The issues of safety and efficacy of certain vaccines remains extremely contentious. The venues for this debate have included periodicals, documentary films, and an ever-increasing number of on-line sites. While debat... The issues of safety and efficacy of certain vaccines remains extremely contentious. The venues for this debate have included periodicals, documentary films, and an ever-increasing number of on-line sites. While debate in science is not only a common occurrence but a fundamental tenet of the scientific community, it only works when divergent opinions can be heard. When those who hold an opposing opinion are denigrated and/or marginalized by those holding the majority opinion such as in the issue of vaccination, where cultural authority for the issue is owned by the profession of medicine, both science and the public lose. What is often forgotten are the benefits derived from the questioning of drug safety that not only extends to the public but to physicians who rely on the truthfulness and accuracy of the information that is being supplied to them by manufactures and government agencies. While most physicians believe they are functioning in their patient’s best interest when making vaccine recommendations, these recommendations by in large have become a matter of rote and are made because most physicians have bought into the “vaccines are safe” mantra. What most physicians don’t realize is they have unknowingly been recruited by big pharma to assist in shutting down the vaccination debate. This suppression of vaccine opposition even among academics, is becoming more commonplace and will lead down a slippery slope that will silence opposition science, and the dangers that come with this. Those who question vaccine safety have been ostracized, misquoted and even made to appear mentally ill by those who hold the majority opinion on the issue. Physicians who question vaccine safety have had their licenses threatened or have been fired from positions. Tactics such as name calling and the use of terms such as pseudo-science, (even when the evidence being presented is from widely accepted peer-reviewed journals) or “conspiracy theorists” which has the effect of placing those holding the minority opinion in the category of such groups as 9/11 truthers, are not uncommon. Other methods of curtailing the presentation of opposing vaccine views have included pressuring venues not to allow anti-vaccination proponents to appear, or using the media to “expose” anti-vaccination groups as “crack-pots” while simultaneously presenting the majority opinion and the presenters as the sole arbiters on the issue. The more extreme elements of the pro-vaccine group will even make the statement that the issue is settled and there is no need for discussion. “Has there ever been a society which has died of dissent? Several have died of conformity in our lifetime.” Jacob Bronowski in Science and Human 展开更多
关键词 Vaccine Opposition Human Papillomavirus Vaccines Adverse Reactions Gardasil^(■) Cervarix^(■)
下载PDF
从宫颈癌疫苗佳达修和卉妍康看跨国公司的专利运营 被引量:1
3
作者 王璟 卫军 +2 位作者 冯晓亮 王超 韦炜 《中国新药杂志》 CAS CSCD 北大核心 2015年第20期2295-2300,共6页
佳达修和卉妍康已销售近10年,期间再无其他宫颈癌疫苗产品进入全球市场。本文对默克公司和GSK从众多抗肿瘤疫苗研发公司中脱颖而出背后的专利运营策略进行了深度剖析,提出了有效构建专利组合的层次和方法,并且基于中小型医药企业常面对... 佳达修和卉妍康已销售近10年,期间再无其他宫颈癌疫苗产品进入全球市场。本文对默克公司和GSK从众多抗肿瘤疫苗研发公司中脱颖而出背后的专利运营策略进行了深度剖析,提出了有效构建专利组合的层次和方法,并且基于中小型医药企业常面对的已经形成产业专利壁垒的形势,针对如何开发专利资产来支撑企业竞争力提升的策略模式提出了相关建议。 展开更多
关键词 专利运营 专利组合 宫颈癌疫苗 佳达修 卉妍康
原文传递
人乳头瘤病毒疫苗预防宫颈癌的研究进展 被引量:3
4
作者 杨菁 皮洁 程苾恒 《世界临床药物》 CAS 2016年第12期849-853,共5页
用于女性宫颈癌预防的人乳头瘤病毒(HPV)二价疫苗(希瑞适)为针对HPV16和18型疫苗,即将在我国大陆上市。肿瘤的预防在国内尚未普及,对HPV的认知有限,肿瘤疫苗的国内应用也将面临挑战。本文简要阐述HPV生物学特性,介绍HPV与宫颈癌的相关性... 用于女性宫颈癌预防的人乳头瘤病毒(HPV)二价疫苗(希瑞适)为针对HPV16和18型疫苗,即将在我国大陆上市。肿瘤的预防在国内尚未普及,对HPV的认知有限,肿瘤疫苗的国内应用也将面临挑战。本文简要阐述HPV生物学特性,介绍HPV与宫颈癌的相关性、HPV疫苗的机制以及临床应用。 展开更多
关键词 人乳头瘤病毒(HPV) 宫颈癌 疫苗 希瑞适
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部